Table 1.1 Number of ConAgra products by country in Euromonitor International categories

Transcription

1 CONAGRA Products included There were 1,254 identified products manufactured by ConAgra in five countries. There was sufficient nutrient information for 1,036 products to generate a Health Star Rating and for 1,151 to generate results for the WHO Euro analysis. There were 103 products (8%) with insufficient nutrient information to calculate either a HSR or a WHO Euro result. Table 1.1 shows the breakdown of products in each category by country. Table 1.1 Number of ConAgra products by country in Euromonitor International categories Breakf Dairy Edib Processed Processed Ready Sauces, Savour Spread Total % ast le Fruit and Meat and Meals Dressings y s sales* Cereal Oils Veg Seafood and Snacks Condiment s India Mexico New Zealand South Africa USA ,166 82% Total ,254 83% * Note that this value indicates % sales from included categories for each country The five countries used in this analysis represented 94% of ConAgra s total global food and beverage sales in Of these five countries, the US represents the highest revenue (more than $6 billion) and South Africa the lowest revenue (less than $4 million). Within each country, the included categories represented between 82% and of product sales, however it is unknown whether we have captured every product for sale in every country. Of the nine product categories included in analysis, Ready Meals represented the largest number of products and the highest sales value. 1

2 Mean HSR Mean HSR ANALYSIS 1 and 2: Country and category rankings based upon mean nutrient profile of ConAgra products and sales-weighted mean nutrient profile of ConAgra products Figure 1.1 Mean Health Star Rating and sales-weighted mean Health Star Rating by country for ConAgra products India USA Mexico South Africa New Zealand Total Mean HSR Sales-weighted HSR Figure 1.2 Mean Health Star Rating by category for ConAgra products

3 % products with HSR>=3.5 ConAgra had a relatively high overall mean HSR of 3.2, which decreased slightly to 2.7 when results were weighted by sales (Figure 1.1) illustrating that its products with slightly lower HSRs account for a relatively larger proportion of sales than those with higher HSRs. Out of the five countries included in ConAgra s analysis, India had the highest mean HSR before results were weighted by sales (3.5) but was overtaken slightly by Mexico once results were weighted by sales (3.6). New Zealand had the lowest mean HSR both before and after sales-weighting of results (2.3). When ConAgra s results were examined by category (Figure 1.2), the highest mean HSR was seen in the Processed Fruit and Vegetables category (4.1), followed by Edible Oils (3.9) and Spreads, with Dairy having the lowest mean HSR of all ConAgra product categories (2.1). The reason for the Dairy category scoring so low related to the types of products sold by ConAgra, with the majority of Dairy products being margarines and whipped cream products. Note that all analyses were done using data per 100g/mL, which is an important consideration for ConAgra as margarine products for example are consumed in small amounts relative to foods in other categories and so likely contribute less to daily nutrient intake compared to other food categories, despite their low HSR results. An important consideration when examining ConAgra s results is that the highest ranked category, Processed Fruit and Vegetables, represented a much lower proportion of sales across the five countries, around half the sales that the lower-ranked Savoury Snacks category represented. ANALYSIS 3 and 4: Country and category rankings based upon proportion of ConAgra products considered healthy and sales-weighted proportion of ConAgra products considered healthy Figure 1.3 Proportion of products considered healthy using the Health Star Rating by country for ConAgra products % 75% 66% 64% 55% 43% 44% 33% 17% 17% India USA Mexico New Zealand South Africa Total % healthy Sales-weighted % healthy 3

4 % products with HSR>=3.5 Figure 1.4 Proportion of products considered healthy using the Health Star Rating by category for ConAgra products % 85% 7 43% 4 29% 64% 23% 13% Overall, ConAgra had a high proportion of sales across all five countries with an HSR of 3.5 or greater (64%), however this decreased to 44% when results were weighted by sales (Figure 4.3) illustrating that products of lower nutritional quality account contributed more to annual 2016 sales than products of higher nutritional quality. ConAgra India had both the highest mean HSR of all countries as well as the highest proportion of products receiving an HSR of 3.5 or more (77%). Mexico and the US showed dramatically different results before and after sales-weighting of results, with the USA showing a decrease in the proportion of healthy products when salesweighting was applied and Mexico showing an increase (Figure 1.3). No products in South Africa received an HSR of 3.5 or above. The same categories that received the highest overall mean HSR also had the highest proportion of products receiving >=3.5 HSR (Figure 1.4). 4

5 % products eligible % products eligible ANALYSIS 5 and 6: Country and company rankings based upon proportion of ConAgra products meeting WHO Euro criteria Figure 1.5 Proportions of ConAgra products meeting WHO Euro criteria for marketing to children by Country % 42% 37% 32% 34% 27% 12% USA India Mexico New Zealand South Africa Total % eligible Sales-weighted % eligible Figure 1.6 Proportions of ConAgra products meeting WHO Euro criteria for marketing to children by Category % 38% 31% 5% 37% Overall just over a third of ConAgra products (37%) were eligible for marketing to children using the WHO Euro criteria (Figure 1.5), decreasing slightly to 34% when results were weighted by sales. The US had the highest proportion of products eligible for marketing to children (39%) before sales-weighting was undertaken, with India ranking first once sales-weighting was 5

6 applied. However, despite India s dramatic increase in proportion of products eligible for marketing from 27% to 9, the majority of product sales globally derived from the US and so the overall change in the proportion of products eligible for marketing did not change dramatically. of ConAgra products in the Edible Oils category were eligible for marketing to children, followed by 69% of Ready Meals and 38% of Processed Meat and Seafood, with no Breakfast Cereals, Savoury Snacks or Spreads being eligible. This result differs from the HSR results which resulted in of Spreads receiving an HSR of 3.5 or above, yet being ineligible for marketing to children using the WHO Euro criteria. Analysis 7: Table 1.2 Mean HSR by Euromonitor International subset for each country India Mexico New South USA Zealand Africa Edible Oils Savoury Snacks Conagra sells only two of its categories in more than one country. The nutritional quality of its edible oils varies considerably between India and Mexico, though is relatively high in both, with a mean HSR of 3.5 in India and 4.6 in Mexico. Similarly, its savoury snacks in the five countries vary from a mean HSR of 2.1 in the U.S. to 3.5 in India the threshold to be considered healthy. While these variations may be in part due to different products within the category being sold in each country, it may also be due to different recipes being used for the same products in different countries. 6

7 ATNF disclaimer As a multi-stakeholder and collaborative project, the findings, interpretations and conclusions expressed in this document may not necessarily reflect the views of all members of ATNF s stakeholders or the organizations they represent or its funders. This document is intended to be for informational purposes only and is not intended as promotional material in any respect. This document is not intended to provide accounting, legal or tax advice or investment recommendations. While based on information believed to be reliable, no guarantee can be given that it is accurate or complete. The user of the document and the information in it assumes the entire risk of any use it may make or permit to be made of the information. NO EXPRESS OR IMPLIED WARRANTIES OR REPRESENTATIONS ARE MADE WITH RESPECT TO THE INFORMATION (OR THE RESULTS TO BE OBTAINED BY THE USE THEREOF), AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, ALL IMPLIED WARRANTIES (INCLUDING, WITHOUT LIMITATION, ANY IMPLIED WARRANTIES OF ORIGINALITY, ACCURACY, TIMELINESS, NON-INFRINGEMENT, COMPLETENESS, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE) WITH RESPECT TO ANY OF THE INFORMATION ARE EXPRESSLY EXCLUDED AND DISCLAIMED. Without limiting any of the foregoing and to the maximum extent permitted by applicable law, in no event shall Access to Nutrition Foundation, nor any of its respective affiliates, have any liability regarding any of the Information for any direct, indirect, special, punitive, consequential (including lost profits) or any other damages even if notified of the possibility of such damages. The foregoing shall not exclude or limit any liability that may not by applicable law be excluded or limited. The George Institute Disclaimer The data used in this scorecard is taken from The George Institute for Global Health (The George Institute) publications Report on the comparative nutritional profile of food and beverage products marketed by the 21 largest global companies in nine countries with input from ATNF. The sections involving analysis of sales-weighted data were prepared by ATNF under the terms of their licence to use Euromonitor International data (Euromonitor International: Packaged Food, 2017 Edition). ATNF assumes responsibility for this aspect of the analysis. While The George Institute has taken reasonable precautions to verify the information contained in the report, it gives no warranties and makes no representations regarding its accuracy or completeness. The George Institute excludes, to the maximum extent permitted by law, any liability arising from the use of or reliance on the information contained in this report. Euromonitor International Disclaimer Although Euromonitor International makes every effort to ensure that it corrects faults in the Intelligence of which it is aware, it does not warrant that the Intelligence will be accurate, up-to-date or complete as the accuracy and completeness of the data and other content available in respect of different parts of the Intelligence will vary depending on the availability and quality of sources on which each part is based. Euromonitor International does not take any responsibility nor is liable for any damage caused through the use of our data and holds no accountability of how it is interpreted or used by any third party. 7